| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122211 HIV integrase inhibitors, pharmaceutical compositions and methods for their use |
| 06/08/2006 | US20060122207 Imidazol derivatives as Raf kinase inhibitors |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122197 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122191 N-(indolethyl-)cycloamine compounds |
| 06/08/2006 | US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/08/2006 | US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122175 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/08/2006 | US20060122063 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 06/08/2006 | US20060122062 2,2,2-trifluoro-N-[5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridinylidene]-acetamide; herbicides; 1-phenylazinethione and 1-phenylchloroazinium intermediates; 1-phenylpyridones: 5-methyl-1-(3-trifluoromethyl-phenyl)-2(1H)-pyridinone |
| 06/08/2006 | CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | CA2589740A1 Cyclic iminocarbamates and use thereof |
| 06/08/2006 | CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors |
| 06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
| 06/08/2006 | CA2558647A1 Insecticidal n-substituted sulfoximines |
| 06/07/2006 | EP1666538A1 Azo metal chelate coloring matter and optical recording medium |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
| 06/07/2006 | EP1664063A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 06/07/2006 | EP1664041A1 Phenyl-carboxamide compounds useful for treating pain |
| 06/07/2006 | EP1664040A1 Gyrase inhibitors |
| 06/07/2006 | EP1664035A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1664030A1 Quinazoline derivatives |
| 06/07/2006 | EP1664029A1 Quinazoline derivatives as antitumor agents |
| 06/07/2006 | EP1664028A1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 06/07/2006 | EP1664026A1 Mitotic kinesin inhibitors |
| 06/07/2006 | EP1664025A1 Pyrrol derivatives with antibacterial activity |
| 06/07/2006 | EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors |
| 06/07/2006 | EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 06/07/2006 | EP1664016A2 Therapeutic agents useful for treating pain |
| 06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
| 06/07/2006 | EP1664006A2 Modulators of atp-binding cassette transporters |
| 06/07/2006 | EP1664005A1 Thiazole derivatives as cannabinoid receptor modulators |
| 06/07/2006 | EP1663988A1 Benzyl-benzimidazolyl derivatives |
| 06/07/2006 | EP1663979A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 06/07/2006 | EP1663966A1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/07/2006 | EP1663965A2 Thrombin receptor antagonists |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663235A1 Capped pyrazinoylguanidine sodium channel blockers |
| 06/07/2006 | EP1663228A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 06/07/2006 | EP1663210A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1599878B1 Optical recording materials having high storage density |
| 06/07/2006 | EP1585725A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1148783B1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 06/07/2006 | CN1784416A 9-ketospinosyn derivatives |
| 06/07/2006 | CN1784399A 3-carbonylaminothiophenes and their use as fungicides |
| 06/07/2006 | CN1784393A Chemical compounds |
| 06/07/2006 | CN1784387A Benzimidazole derivatives |
| 06/07/2006 | CN1784383A N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 06/07/2006 | CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems |
| 06/07/2006 | CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents |
| 06/07/2006 | CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds |
| 06/06/2006 | US7057048 Androgen receptor antagonists |
| 06/06/2006 | US7057046 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056923 Anticoagulants |
| 06/06/2006 | US7056917 Prevent drug resistance |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/06/2006 | CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists |
| 06/01/2006 | WO2006058338A2 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| 06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 06/01/2006 | WO2006057448A1 Arylalkanoic acid derivative |
| 06/01/2006 | WO2006057113A1 Cyanine compound, optical recording material utilizing the compound, and optical recording medium |
| 06/01/2006 | WO2006033995A3 Thiazolidin-4-ones having anti-hepatitis b activity |
| 06/01/2006 | WO2006028957A8 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 06/01/2006 | WO2006016067A3 Pyrido-pyrido pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116514 4-Hydroxy-2-methyl-N-ethyl-N'-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide = <0.05% ("ethylamide") after crushing the wet filter cake obtained by filtering a precipitate obtained by the acidification of a solution of crude meloxicam and sodium methylate; boil,cool, dry |
| 06/01/2006 | US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | US20060116408 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents; methyl 4-(5-chloro-3-methylbenzo[b]thiophene-2-sulfonylamino)-3-methanesulfonylbenzoate |
| 06/01/2006 | US20060116407 Amide derivatives |
| 06/01/2006 | US20060116406 e.g. 4-(4-fluorophenyl)-7-({5-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-1,3-thiazol-2yl}thio)-2H-chromen-2-one; 5-lipoxygenases inhibitor; anti-asthmatic, anti-allergic, anti-inflammatory, cytoprotective and anti-artherosclerotic agents; angina, cerebral spasm, nephritis, hepatitis |
| 06/01/2006 | US20060116405 Indol derivatives and their use as 5-ht ligands |
| 06/01/2006 | US20060116400 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 06/01/2006 | US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 06/01/2006 | US20060116390 Hepatitis c virus inhibitors |
| 06/01/2006 | US20060116389 Antibacterial oxazolidinones |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116384 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |